The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.
暂无分享,去创建一个
I. Campbell | S. Rockman | R. Whitehead | W. Phillips | R. J. Thomas | A. Philp | Robert J. S. Thomas | E. Vincan | C. Leet
[1] D. Roymans,et al. Phosphatidylinositol 3-kinases in tumor progression. , 2001, European journal of biochemistry.
[2] H. Chapuis,et al. A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells , 2000, Oncogene.
[3] Chen-Yang Shen,et al. PIK3CA as an oncogene in cervical cancer , 2000, Oncogene.
[4] Domenico Coppola,et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer , 2000, Oncogene.
[5] B. Vanhaesebroeck,et al. The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.
[6] M. Waterfield,et al. Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.
[7] Julian Downward,et al. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.
[8] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[10] C. Mitchell,et al. Increased levels of phosphatidylinositol 3‐kinase activity in colorectal tumors , 1998, Cancer.
[11] A. Schulz,et al. An oncogenic fusion product of the phosphatidylinositol 3-kinase p85β subunit and HUMORF8, a putative deubiquitinating enzyme , 1998, Oncogene.
[12] J. Downward,et al. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3‐kinase , 1998, The EMBO journal.
[13] Y. Yazaki,et al. p85α Gene Generates Three Isoforms of Regulatory Subunit for Phosphatidylinositol 3-Kinase (PI 3-Kinase), p50α, p55α, and p85α, with Different PI 3-Kinase Activity Elevating Responses to Insulin* , 1997, The Journal of Biological Chemistry.
[14] C. Kahn,et al. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain , 1996, Molecular and cellular biology.
[15] R. Bast,et al. A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. , 1994, Human molecular genetics.
[16] I Gout,et al. PI 3‐kinase is a dual specificity enzyme: autoregulation by an intrinsic protein‐serine kinase activity. , 1994, The EMBO journal.
[17] R. Whitehead,et al. Retention of tissue‐specific phenotype in a panel of colon carcinoma cell lines: Relationship to correlates , 1992 .
[18] R. Whitehead,et al. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: relationship to clinical correlates. , 1992, Immunology and cell biology.
[19] F. Walker,et al. A new gastric carcinoma cell line (LIM1839) derived from a young caucasian male , 1989, International journal of cancer.
[20] R. Whitehead,et al. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. , 1987, Cancer research.
[21] R. Whitehead,et al. A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. , 1985, Journal of the National Cancer Institute.